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ABSTRACT
Introduction: Web-based lifestyle counselling
designed to improve adherence to self-management
behaviours for diet, exercise and medication has been
shown to reduce blood pressure (BP). However, the
long-term clinical outcome of these interventions is not
established. Our aim was to establish whether an
e-counselling program is independently associated with
improved clinical outcomes over a 12-month period,
as defined by the following criteria: (1) reduction of
systolic BP, diastolic BP, pulse pressure and associated
risk factors for cardiovascular events; and
(2) adherence to self-management behaviour (diet,
exercise, smoke-free living and prescribed medication).
Methods and analysis: Reducing risk with e-based
support for adherence to lifestyle change in
hypertension is a two-parallel group, double-blind
randomised controlled trial that will utilise a two
(Groups: e-counselling vs control) by three
(assessment intervals: baseline, 4-month and
12-month outcome) design. BP, lipoprotein cholesterol,
physical activity and dietary behaviours and
psychological distress will be measured at each
assessment. We plan to recruit 528 participants
(35–74 years of age) diagnosed with stage 1 or 2
hypertension (systolic BP, 140–180 mm Hg; diastolic
BP 90–110 mm Hg) from three major cities (Toronto,
London, Vancouver) and one rural area (Grey Bruce
region) across Canada between February 2012 and
July 2015. Controls will receive general educational
e-messages on heart healthy living and the ecounselling group will receive tailored e-messages that
are matched to their stage of readiness for change. For
both groups, e-messages will be sent proactively on a
weekly basis during months 1–4, then bi-weekly
during months 5–8 and then monthly during months
9–12.
Ethics and dissemination: Ethical approval has
been obtained from all recruitment sites. This will be
one of the first studies to evaluate the long-term
efficacy of preventive e-counselling strategies for
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ARTICLE SUMMARY
Article focus
▪ This article describes the study protocol of a
multicentred double-blind randomised controlled
trial evaluating the effectiveness of a 12-month
lifestyle e-counselling program in reducing risk
factors for cardiovascular disease and improving
adherence to self-management behaviours in
patients with hypertension.

Key messages
▪ An e-counselling strategy is becoming increasingly
prominent in the development of communitybased initiatives for prevention.
▪ The long-term clinical outcome of these interventions is not established.
▪ Reducing risk with e-based support for adherence to lifestyle change in hypertension (REACH)
will be one of the first studies to evaluate the
long-term efficacy of preventive e-counselling for
cardiovascular disease prevention in patients
with hypertension, and the findings from this
study will be used to guide the ongoing development of e-counselling services at the Heart and
Stroke Foundation of Canada.

Strengths and limitations of this study
▪ A key strength of this trial is that the intervention is
grounded in a clinical applied theory of behaviour
change. Also, an unbiased response by participants to the REACH protocol will be facilitated by
frequent and sustained e-messages that are supportive of controls and the Intervention group.
▪ A limitation of REACH is that any supplementary
heart health program in which participants are
enrolled during the REACH trial is only controlled
statistically, not methodologically. Owing to technical limitations, there is only limited interactivity
in the interface between the e-counselling
program and participants.

1
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INTRODUCTION
Individuals with hypertension are at increased risk for
cardiovascular disease (CVD), stroke, coronary heart
disease, heart failure and CVD mortality.1 Hypertension
is prevalent among 19–21% of Canadian adults
20–79 years of age, and its prevalence rises to 53%
among adults 60–79 years of age and higher among
elderly adults.2 Hypertension is treated and controlled
among only 66% of Canadian adults.2 3 This is a matter
of concern as the risk of cardiovascular mortality among
adults 40–69 years of age rises with elevated blood pressure (BP), doubling with each increase of 20mm Hg systolic or 10 mm Hg diastolic, from the base index of
115/75 mmHg.4
Best practice guidelines in North America5 6 and
Europe7 advocate the strategy of combining pharmacotherapy with lifestyle counselling for patients diagnosed
with hypertension and/or those who are at elevated risk
for CVD. Meta-analyses indicate that programs aimed at
improving self-management behaviours signiﬁcantly
decrease systolic BP (SBP) by 3.0–8.7 mm Hg relative to
controls.8–10 A major challenge for a community-based
CVD prevention strategy is to extend the reach of therapeutic lifestyle counselling to individuals with hypertension and/or high CVD risk without overtaxing patient
care resources. Currently, 73% of the Canadian population reports personal access to the internet, which
includes 61–69% of Canadians in the two lowest income
quartiles, and 61% of older Canadians (aged
55–64 years).11 The use of e-based programs that are
designed to improve self-management behaviours for
diet, exercise, smoke-free living and medication adherence may be well suited to meet this challenge.
Our previous trials of COHRT12 and I-START13 have
shown that it is feasible to apply an evidence-based
model of behavioural counselling with motivational
interviewing14 to a telehealth or e-based program in
order to achieve a reduction in SBP, diastolic BP (DBP)
and pulse pressure (PP). This was achieved by means of
increased adherence to self-reported diet and exercise,
and it was independent of the therapeutic beneﬁt of
medications. However, it is not established whether
e-counselling improves clinical outcome and adherence
over a long-term interval of at least 12 months. Thus, the
aim of the reducing risk with e-based support for adherence to lifestyle change in hypertension (REACH) trial
is to establish whether an e-counselling program is independently associated with improved clinical outcomes
over a 12-month period, as deﬁned by the following criteria: (1) reduction of BP and associated risk factors for
2

cardiovascular events; and (2) adherence to selfmanagement behaviour for diet, exercise, smoke-free
living and prescribed medication.
Our primary hypotheses are that e-counselling (vs
control) will signiﬁcantly reduce (1) SBP, DBP and PP at
the 4-month and 12-month assessment intervals, as measured by a validated protocol for automated BP assessment in the clinic; and (2) lipoprotein cholesterol
(total, low-density and total/high-density ratio) and the
Framingham index of 10-year absolute risk for CVD.
Our secondary hypotheses are that e-counselling (vs
control) will signiﬁcantly increase adherence to selfmanagement behaviours at the 4-month and 12-month
outcomes, as measured by the following objective and
validated indices: mean 4-day step count recorded by a
triaxial pedometer, dietary sodium ≤100 mmol/day measured by 24 h urinary sodium, smoke-free living measured by salivary cotinine, fruit and vegetable intake ≥9–
12 servings/day as measured by the Diet History
Questionnaire (DHQ) assessment and physical activity
≥150 min/week as measured by the Recent Physical
Activity Questionnaire (RPAQ); and medication adherence as deﬁned by the medication possession ratio
(derived from the pharmacy reﬁll data) among participants who are prescribed antihypertensive medications
at baseline.

METHODS
Study design
REACH is a two-parallel group, double-blind randomised
controlled trial that will utilise a two (groups:
e-counselling vs control) by three (assessment intervals:
baseline, 4-month and 12-month outcome) design.
Randomisation will be blocked within each of our four
recruitment sites (Toronto, London, Grey Bruce region
and Vancouver) to ensure overall balance (1:1) in the
number of participants assigned to the two groups. This
trial will be double blind according to CONSORT standards.15 The e-counselling and control groups will be
informed that they will receive e-messages “...that are
designed to support a heart healthy lifestyle which is an
essential component of blood pressure management.”
Therefore, all participants will be unaware of whether
their intervention is the ‘experimental’ treatment. A randomisation code will be embedded into each participant
ID number, which is known only to the Research
Coordinator but not to the Principle Investigators or
research assistants who administer the assessments.
Blinding will be maintained during all assessment sessions (baseline, 4-month and 12-month intervals) and
during the data processing and analysis of clinical outcomes. Moreover, participants will be instructed to not
discuss their e-based treatment during these assessments.
Over the 12-month intervention, 28–30 e-based messages
(dependent on # weeks/month) will be sent to controls
and e-counselling participants—see table 1. E-messages
will be sent on a weekly basis during months 1–4, then
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cardiovascular disease prevention in patients with hypertension.
Findings from this study will be used to guide the ongoing
development of e-counselling services.
Trial Registration: Clinicaltrial.gov NCT01541540; http://
clinicaltrials.gov/ct2/show/NCT01541540.
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Schedule:

Months 1–4=weekly

Months 5–8=bi-weekly

Months 9–12=monthly

Number of e-messages

17–18

8–9

4

bi-weekly between months 5 and –8, and then monthly
between months 9 and –12 (ﬁgure 1).
Inclusion/exclusion criteria
Participants will be 35–74 years of age and diagnosed
with stage 1 or 2 hypertension (SBP, 140–180mm Hg;
DBP 90–110mm Hg). Among participants not prescribed medication, hypertension status will be conﬁrmed at baseline by a medical doctor or a nurse
practitioner. Participants prescribed antihypertensive
drugs will be required to have the prescription
unchanged for at least 2 months before enrolment. In
order to prevent ‘ﬂoor effects’ for the analysis of
primary outcomes, participants prescribed antihypertensive medications will also be required to have a baseline
BP that is at least in the high normal range
(SBP≥130mm Hg and/or DBP≥85mm Hg). Exclusion
will be based on diagnosis of sleep apnoea, kidney
disease, major psychiatric illness (eg, psychosis), alcohol
or drug dependence in the previous year; pregnancy,
institutional residence or an inability to comprehend
English.
Experimental versus control interventions
Control
An ethical imperative for any long-term trial of preventive e-counselling for hypertension is to ensure that the
control arm receives essential information about preventive guidelines for BP management. From a methodological perspective, it is a priority to balance e-based
support across the control and experimental arms of the
trial to ensure that potential improvement in clinical
outcome is not confounded by differences in nonspeciﬁc support and attention. Therefore, controls will
be supported with educational material that will include

brief articles on heart healthy living that are selected
from the Resources section of the Heart and Stroke
Foundation Blood Pressure Action Plan. The e-based
articles for controls will provide information regarding
appointments with physicians, BP measurement, lifestyle
and antihypertensive medication.
e-Counselling
Participants will receive e-messages that will guide them
in self-assessing their current stage of motivational readiness for adhering to self-management behaviours as a
daily lifestyle routine. These participants will be directed
to select their behaviour change priority according to
the recommended goals for exercise, diet, smoke-free
living and adherence to prescribed antihypertensive
medications. In keeping with the guidelines from motivational interviewing, participants will be sent an ecounselling message that is tailored to their self-reported
stage of readiness for change. Each message will provide
a link to the e-counselling program on the Heart and
Stroke Foundation website. A menu of stage-appropriate
e-resources for lifestyle change will be presented which
will include brief video-taped counselling messages that
validated to each participant’s presenting stage of readiness for change. This feedback will be supplemented by
online self-monitoring charts and e-handouts that
provide guidelines/tips for initiating or maintaining lifestyle change. The content of each video-taped message
will be consistent with clinical guidelines for motivational interviewing,14 as established in our previously
adapted manual.16 Accordingly, the video clips will highlight key clinical features which are not only applicable
to our targeted self-management behaviours, but also
promote the following: validation of the participant’s
presenting stage of readiness for behaviour change,

Figure 1 Schematic summary of reducing risk with e-based support for adherence to lifestyle change in hypertension.
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Table 1 Twelve-month schedule for pro-active e-messaging to e-counselling and control groups
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Recruitment and randomisation
We will replicate the successful recruitment strategy from
our previous trial (I-START)13 by informing online visitors to the Heart and Stroke Foundation Risk
Assessment Program about our study. This message will
only appear once participants conﬁrm online that they
reside in our participating sites within Canada: Toronto,
London, the Grey Bruce region of Ontario and
Vancouver. Eligible participants will then undergo clinical assessment at the local participating sites:
(1) University Health Network, Toronto, (2) London
Health Sciences Center, Univ. of Western Ontario,
London, (3) Grey Bruce Health Unit, Owen Sound and
(4) UBC, Vancouver Coastal Health, Vancouver.
Recruitment will take place between February 2012 and
July 2015. The Research Coordinator and Principal
Investigator will be based in the Behavioural Cardiology
Research Unit, University Health Network, Toronto and
a Coordinator/Research Assistant will be based in each
recruitment site.
Randomisation will be conducted by a computer
program (randomize.net) using randomly permuted
blocks to assign participants to control or e-counselling.
The randomisation code will be hidden from research
assistants during assessments and data processing of the
primary and secondary outcomes. An unbiased response
by participants to the REACH protocols will be facilitated by frequent and sustained e-messages (table 1)
that are likely to be perceived as being supportive in
nature.
Assessment protocol
Baseline, 4-month and 12-month assessments in REACH
will be scheduled between 08:00 and 12:00 to minimise
diurnal BP variability. Participants will be instructed to
fast for 12 h in order to obtain a valid proﬁle of lipoprotein cholesterol. They will also be directed to refrain
from smoking for at least 4 h, caffeine for 12 h and
strenuous exercise for 24 h prior to their appointment.
Anthropometric characteristics, medical history and
medication information will be collected. Medication
adherence will be calculated by the Medication
Possession Ratio, which is deﬁned as the quantity of antihypertensive medication that has been utilised over each
4-month interval versus the quantity that has been prescribed, based upon pharmacy reﬁll data.17 Resting BP,
physical activity, dietary behaviour, psychological distress
and participant’s readiness to change will be examined
at each assessment interval. Feedback of the
Framingham 10-year absolute risk for CVD will be provided to the participants at the end of each assessment.
4

Blood pressure
Primary outcome measures of SBP, DBP and PP will be
assessed by a validated protocol for automated BP assessments using the BpTRU device. Participants will be seated
for at least 5 min prior to activation of BpTRU. The BP
cuff will be applied to the left arm of the participant by a
nurse or trained research assistant. An initial BP measurement will be recorded. The nurse/research assistant will
then exit the room while the BpTRU device completes an
automated series of ﬁve BP recordings. A 1 min interval
will separate each of these recordings. The recorded BP
(SBP, DBP, PP) at each assessment interval will be the
mean of these ﬁve BpTRU measurements.
Diet
Adherence to a sodium-restricted diet will be evaluated
by 24 h urinary sodium analysis and deﬁned as
≤100 mmol/day. Adherence to recommended guidelines for daily intake of fruits, vegetables and supplementary dietary fat will be evaluated by the NIH/NCI DHQ,
which has established validity18 and has been successfully
adapted for a Canadian population19 and used in
Canadian studies.20
Physical activity/exercise
Daily activity will be deﬁned as the mean 4-day number
of steps recorded on a tri-axial pedometer (LifeSource/
A&D XL-18CN Activity Monitor). Adherence to physical
activity will also be measured by a validated assessment:
RPAQ.21 RPAQ measures self-reported time in activities
(associated with light, moderate and intense energy
expenditure) at home, work and recreational settings
over the previous month.
Salivary cotinine
Physiological evaluation of smoking status will be recorded
by salivary cotinine among participants who are current
smokers at baseline. Positive exposure to nicotine, which is
consistent with smoking, will be deﬁned by cotinine
≥10 ng/mL. This evaluation will screen for exposure to
nicotine replacement therapy, which would confound the
interpretation of the cotinine index.
Readiness for change
Prochaska’s Transtheoretical algorithm will be used to
operationally deﬁne motivational readiness to initiate or
maintain self-management behaviours that include
planned exercise, daily activities for active living, fruit
and vegetable intake, salt use, alcohol consumption and
smoke-free living. The stages of change are conventionally deﬁned as follows: precontemplation (not ready to
adhere to the target behaviour in the next 6 months),
contemplation (ready to adhere to the target behaviour
in the next 6 months), preparation (ready to adhere to
the target behaviour in the next 4 weeks), action
(adhere to the behaviour but for less than 6 months)
and maintenance (adhere to the behaviour for
6 months or more).22
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individual review of salient pros versus cons for change
that determine decisional balance, resolution of ambivalence for change, increased efﬁcacy for initiating
change, and review of social and cognitive-behavioural
skills for relapse prevention to maintain adherence.
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Sample size
The sample size estimation was based on the
meta-analysis by Neubeck et al26 who evaluated the efﬁcacy of randomised controlled trials of preventive telehealth and e-based programs in modifying BP: weighted
mean difference in SBP between experimental versus
control groups=–4.69 mm Hg, common pooled variance=354, pooled SD=18.81. In order to replicate this
outcome, the estimated sample=254 participants per
group (using a two-parallel group design, type 1
error=5% and power=80%). Dropouts from this study
will be interpreted as an intervention failure. Therefore,
we will recruit a sample of 528 participants.
Statistical analysis
Linear Mixed Models with a random effects intercept
will be used to evaluate whether within-participant
change across assessment intervals is independently and
signiﬁcantly associated with the e-counselling group, for
each primary and secondary outcome.27 Generalised
estimation equations for repeated measures will be used
to analyse categorical outcomes (eg, smoking cessation
status). All signiﬁcant interactions or main effects in our
statistical models will be followed up with post hoc contrasts, using a Bonferroni correction for the statistical signiﬁcance criterion of p<0.05.
Ethics and dissemination
All participants will be provided written informed
consent. Ethics approval will be renewed on an annual
basis.
Meta-analytic evidence clearly supports the use of lifestyle counselling to reduce SBP and risk for premature
mortality. Programs aimed at improving selfmanagement behaviours signiﬁcantly decrease SBP by
3–8.7 mm Hg relative to controls.8–10 In order to optimise the efﬁcacy of lifestyle change interventions, it is
essential to develop strategies to sustain long-term adherence to recommended self-management behaviours.
Once the long-term efﬁcacy of preventive e-counselling is established as exempliﬁed by this trial, it is likely
that this strategy will become increasingly prominent in
the development of community-based initiatives for CVD
prevention. This point is highlighted by evidence that
there is only low-to-moderate long-term adherence to
recommended standards for exercise, diet and smokefree living following conventional behaviour change programs.28–30 Moreover, there is high potential to use
e-counselling to increase long-term adherence to antihypertensive pharmacotherapy. Our team and others have

reported that non-adherence to antihypertensive medication ranges from 15% to 50%,17 31 while persistence
with antihypertensive medications diminishes over time
for approximately 22–50% of patients.31 32
Knowledge translation of ﬁndings obtained from this
proposed trial will be utilised to guide the ongoing development of e-counselling services provided by the Heart
and Stroke Foundation. This e-based service can be currently accessed through three portals: My Blood Pressure
Action Plan, My Heart and Stroke Risk Assessment and
My Healthy Weight Action Plan: http://www.
heartandstroke.com/site/c.ikIQLcMWJtE/b.5374487/k.
62BF/HeartStroke_Action_Plans.htm.
Internet trafﬁc is signiﬁcant on this website. In 2011,
395 044 individuals accessed this website for health information, while 160 600 persons completed the Heart and
Stroke Risk Assessment program.
In sum, we anticipate that ﬁndings from the REACH trial
will have high population impact, given our collaboration
with the Heart and Stroke Foundation of Canada.
Advancements achieved with this trial, concerning the
content and methodology of preventive e-counselling, will
be widely disseminated to the general public and most
likely utilised in follow-up research by our team and others.
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Psychological distress
Diagnostic screening tools will be used to assess anxiety
and depression: Generalized Anxiety Disorder-7 and the
Patient
Health
Questionnaire-9,
respectively.
Psychological stress will be assessed using the Perceived
Stress Scale. The validity and reliability of these questionnaires are well established.23–25
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